These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9289251

  • 1. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D, Keïta B, Sangaré S.
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [Abstract] [Full Text] [Related]

  • 2. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D, Bechan S, Connolly C, Standing E, Short GM.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [Abstract] [Full Text] [Related]

  • 3. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM, Bakare NA, Onadeko BO.
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 5. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 6. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 7. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [Abstract] [Full Text] [Related]

  • 8. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 9. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov 09; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract] [Full Text] [Related]

  • 10. [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
    Wen S, Su Y, Zhang F.
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec 09; 19(6):357-9. PubMed ID: 9596819
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 09; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 12. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA, Ursov IG.
    Probl Tuberk Bolezn Legk; 2004 Sep 09; (3):21-6. PubMed ID: 15338895
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 09; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 14. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.
    Kekkaku; 1994 Nov 09; 69(11):671-80. PubMed ID: 7837720
    [Abstract] [Full Text] [Related]

  • 15. Short-course treatment in pulmonary tuberculosis.
    East Afr Med J; 1973 Dec 09; 50(12):672-80. PubMed ID: 4132127
    [No Abstract] [Full Text] [Related]

  • 16. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1972 May 20; 1(7760):1079-85. PubMed ID: 4112569
    [No Abstract] [Full Text] [Related]

  • 17. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA.
    Int J Tuberc Lung Dis; 1998 Jan 20; 2(1):10-5. PubMed ID: 9562106
    [Abstract] [Full Text] [Related]

  • 18. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA, Uvarova TE.
    Probl Tuberk Bolezn Legk; 2004 Jan 20; (3):19-21. PubMed ID: 15338894
    [Abstract] [Full Text] [Related]

  • 19. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 20; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 20. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov 20; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.